EMA
- Application: EMEA/H/C/006576
- Local brand name: Viokat
- Indication: Treatment of adult and paediatric patients with Prader-Willi syndrome (PWS).
- Pathway: orphan
- Status: withdrawn
DIAZOXIDE CHOLINE (DIAZOXIDE CHOLINE) regulatory status in European Union.
Yes. EMA has authorised it.
Marketing authorisation holder not available in our data.